Interestingly, in vitro generated CD4+ T cells specific to BCR-ABL immunogenic peptides were shown to proliferate and produce Th1 cytokines in response to HLA-matched CML blasts in absence of exogenous antigen presenting cells [23]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.